CTI LIFE SCIENCES FUND
CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.
CTI LIFE SCIENCES FUND
Industry:
Clinical Trials Life Science Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
514 787 1620
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-10 | Domain Therapeutics | CTI Life Sciences Fund investment in Series A - Domain Therapeutics | 39 M EUR |
| 2022-04-25 | Epitopea | CTI Life Sciences Fund investment in Seed Round - Epitopea | 10.3 M GBP |
| 2020-10-07 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 6 M USD |
| 2020-08-01 | Find therapeutics | CTI Life Sciences Fund investment in Seed Round - Find therapeutics | N/A |
| 2020-06-08 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 3 M EUR |
| 2020-03-06 | Vaxcyte | CTI Life Sciences Fund investment in Series D - Vaxcyte | 110 M USD |
| 2018-06-18 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 2 M USD |
| 2017-10-05 | Visterra | CTI Life Sciences Fund investment in Series C - Visterra | 23.6 M USD |
| 2017-07-27 | PreciThera | CTI Life Sciences Fund investment in Series A - PreciThera | 36 M CAD |
| 2017-06-27 | PHEMI | CTI Life Sciences Fund investment in Series B - PHEMI | 10 M USD |
More informations about "CTI Life Sciences Fund"
CTI Life Sciences Fund - LinkedIn
Exciting News from CTI Life Sciences Fund's portfolio company, Find Therapeutics! Find Therapeutics Announces the Closing of a $8.1M USD Convertible Note Financing with …See details»
CTI Life Sciences Fund - Crunchbase
CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently …See details»
Portfolio - CTI Life Sciences
A Fund I company, GLyPharma Therapeutic Inc. (GlyPharma) was a new company created in Montreal for the purpose of a strategic partnership between Ferring Pharmaceuticals (Ferring), a European pharmaceutical company, …See details»
CTI Life Sciences Fund Successfully Raises $100 Million …
May 10, 2021 About CTI Life Sciences Fund. Based in Montreal, ... Organization Profile. CTI Life Sciences Fund. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a Demo ;See details»
CTI Life Sciences Fund Investor Profile: Portfolio & Exits …
CTI Life Sciences Fund General Information Company Description. Founded in 2006 CTI Life Sciences Fund is a venture capital firm based in Montreal, Canada. The firm prefers to invest in the life sciences and healthcare companies at the …See details»
CTI Life Sciences Fund - Investments, Portfolio & Company Exits
CTI Life Sciences Fund 's most notable exits include Vaxcyte, Amolyt Pharma, and Visterra. Which industries has this organization had the most exits in? Show . Vaxcyte Vaxcyte focuses …See details»
CTI Life Sciences Fund - Synapse Life Science Consortium
Based in Montréal and Toronto, CTI Life Sciences Fund, a Canadian venture firm makes venture capital investments in high quality emerging life science companies at the pre-clinical and …See details»
CTI Life Sciences Fund I: Performance - PitchBook
Mar 31, 2007 CTI Life Sciences Fund I Fund is a venture capital fund managed by CTI Life Sciences Fund. The fund is located in Montreal, Canada and invests in the Canada. The fund …See details»
CTI Life Sciences Fund Successfully Raises $100 Million As A
May 10, 2021 CTI Life Sciences Fund announced today the first closing of its third venture capital fund (“CTI LSF III”), with $100M CDN of capital now available for investment. The new …See details»
CTI Life Sciences - Venbridge
CTI Life Sciences Fund makes venture capital investments in high quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to catalyze, transform and invest in the …See details»
LAURENCE RULLEAU - CTI Life Sciences
Dr Laurence Terrisse Rulleau has been a partner with the CTI Life Sciences fund since 2014 where she has played a key role in the fund's investments but more specifically in the creation …See details»
CTI Life Sciences Fund - CB Insights
Jan 15, 2015 CTI is a Montreal-based limited partnership making venture capital investments in emerging life sciences companies at the start-up and clinical development stage in North …See details»
CTI Life Sciences Fund Raises $100 Million As A First ... - BIOQuébec
MONTREAL, May 10, 2021 /CNW Telbec/ - CTI Life Sciences Fund announced today the first closing of its third venture capital fund ("CTI LSF III"), with $100M CDN of capital now …See details»
CTI Life Sciences Fund holds $100M initial close for 3rd fund
CPE News (5/10/2021) – CTI Life Sciences has held an initial close for its third fund, CTI Life Sciences Fund III, secures $100 million from BDC, Fonds de solidarité FTQ, Caisse de dépôt …See details»
CTI raises $100-million to invest in early-stage Canadian life …
May 10, 2021 CTI Life Sciences Fund has become the latest among Canada’s small coterie of life sciences venture capital firms to raise a new fund to invest in the booming domestic sector.See details»
CTI Life Sciences Fund raises $100 million in first close of third ...
May 10, 2021 Youssef Bennani, managing partner of CTI Life Sciences Fund III, told BetaKit the firm is aiming to raise between $175 million and $200 million overall for this fund. The firm …See details»
CTI Life Sciences Fund secures initial C$100m for third pool
May 10, 2021 Based in Montreal, CTI Life Sciences Fund L.P. was created in 2006. The firm makes venture capital investments mostly in innovative high-quality biotech companies at the …See details»
CTI Life Sciences Fund
Jun 3, 2022 CTI Life Sciences Fund Successfully Raises $100 Million As A First Tranche of its Third Venture Capital Fund Read ArticleSee details»
CTI Life Sciences Fund Successfully Raises $100 Million As A First ...
MONTREAL, May 10, 2021 /CNW Telbec/ - CTI Life Sciences Fund announced today the first closing of its third venture capital fund ("CTI LSF III"), with $100M CDN of capital now …See details»
Canada’s Biotech Reboot: How to keep the vital life sciences sector ...
2 days ago Canada’s life sciences sector has been a paragon of strength and economic vibrancy. Supported by a world-class science and research ecosystem, it’s made the country a …See details»